MRI Safe Implantable Defibrillator Devices Market Is Set To Enjoy A Valuation Of US$ 890 Million In 2022 And To Reach US$ 1.7 Billion By 2032-End; States Fact.MR

19 Jul 2022
www.biospace.com
AcquisitionCollaborate
North America Is Expected To Account For 24.1% Of The Global Market Share for for MRI Safe Implantable Defibrillator By 2022 Demand For MRI Safe Implantable Defibrillator Gadgets Is Growing As A Result Of Factors Such As Rising Ageing Population, Increase In Cardiac Disorders, And Technological Advancements In Products. Fact.MR, a market research and competitive intelligence provider - The global MRI Safe Implantable Defibrillator Devices market would reach US$ 890 Mn in 2022 and have a CAGR of 6.7% from 2022 to 2032. Expanding at a CAGR of 6.7%, the global MRI-safe implantable defibrillator devices market is projected to reach a size of US$ 1.7 billion by 2032. Demand for MRI safe implantable defibrillator gadgets is growing as a result of factors such as rising ageing population, increase in cardiac disorders, and technological advancements in products. Different types of electromagnetic fields are used during MRI imaging procedures and are predicted to interfere with the leads of cardiac pacemakers or defibrillators. Devices that are implanted inside the body of the patient and enable the patient to undergo MRI diagnosis safely are known as MRI safe defibrillators. Better images of soft tissues, such as the spine, are produced by the imaging technique known as magnetic resonance induction. For more insights into the Market, Get A Sample of this Report! Due to changing lifestyle preferences, high incidence of degenerative & chronic diseases, increase in the number of elderly people, and technological advancements in implantable devices such as high-field MRI, superconducting magnets, software applications, and open architecture, the global market for MRI-safe implantable devices is expanding rapidly across geographies. Key Takeaways from Market Study In 2022, North America is expected to account for 24.1% of the global market share. North America dominates the market for MRI safe implantable defibrillator solutions because of the region's sophisticated medical facilities, high rate of implants, and favourable reimbursement environment. Europe is predicted to hold 22.3% of the global market share, in 2022. Growing geriatric population is one of the factors driving the MRI Safe Implantable Defibrillator Devices Market. The global MRI safe defibrillator devices market has been divided into hospitals and ambulatory surgical centers, based on end user “Rising incidences of Chronic Ailments to hold the hopes high for MRI Safe Implantable Defibrillator Market” says a Fact.MR analyst. For Comprehensive Insights Ask An Analyst Here Market Developments There are incredibly few businesses that are engaged in the production of MRI-compatible gadgets. These products were just recently introduced into the market. In April 2014, Medtronic announced that the first implantable defibrillator devices that were MRI-safe had received the CE Mark and were available in Europe. USFDA recently approved the first Medtronic ICD that is MRI-compatible. A majority of the population still uses implantable defibrillators that are not MRI-compatible despite the introduction of MRI-safe devices. Market participants will put more effort into creating novel devices to attract attention across the world. Since 2021, the most frequently used strategies have continued to include technological improvements, new product launches, research and development, acquisitions, expansions, and collaborations. DirectSense Technology, a novel instrument for observing the impact of radiofrequency energy delivery during cardiac ablation procedures, was recently released by Boston Corporation. Key Segments in MRI Safe Implantable Defibrillator Devices Industry Research MRI Safe Implantable Defibrillator Devices Market by Product : Single Chamber Defibrillators Dual Chamber Defibrillators MRI Safe Implantable Defibrillator Devices Market by Modality : MR Conditional Defibrillators MR Safe Defibrillators MRI Safe Implantable Defibrillator Devices Market by End Use : Hospitals Ambulatory Surgical Centers MRI Safe Implantable Defibrillator Devices Market by Region : North America Latin America Europe East Asia South Asia & Oceania MEA Get Customization on this Report for Specific Research Solutions More Valuable Insights Available Fact.MR, in its new offering, presents an unbiased analysis of the global MRI Safe Implantable Defibrillator Devices market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032. The study reveals essential insights by product (single chamber defibrillators and dual chamber defibrillators), by modality (MR conditional defibrillators and MR safe defibrillators), by end-use (hospitals and ambulatory surgical centers), and by region (North America, LATAM, Europe, East Asia, South Asia & Oceania, and MEA). Check out more studies related to Healthcare Industry, conducted by Fact.MR: Immunoglobulins Market - Immunoglobulins Market Analysis, By Application (Neurology, Immunology, Hematology), By Route of Administration (Intravenous, Subcutaneous, Intramuscular), By End-user (Hospitals, Clinics, Homecare) - Global Market Insights 2020-2026 High Performance Liquid Chromatography (HPLC) Market - High Performance Liquid Chromatography (HPLC) Market By Product Type (Instruments, Consumables, Columns, Filters, Vials, Tubes), By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), By End-User - Global Mraket Forecast 2020-2026 Medical Holography Market - Medical Holography Market Analysis By Product (Holographic Display, Holography Microscope, Holographic Prints, Holography Software), By Application (Medical Imaging, Medical Education, Biomedical Research), By End-User, By Region - Global Forecast 2020-2026 Opthalmic Drugs Market - Ophthalmic Drugs Market Analysis By Disease Indication (Dry Eye, Glaucoma, Infection/Inflammation, Retinal Disorders), By Therapeutic Class (NSAIDs, Steroids, Anti-glaucoma Drugs), By Product Type (Prescription Drugs, OTC Drugs) - Global Review 2020-2025 Advanced Wound Care Market - Advanced Wound Care Market By Product Type (Antimicrobial Gels, Antimicrobial Powder, Concentrated Surfactant, Hydrogels Dressings, Skin Protectants, Wound Cleansers, Semi-Permeable Films Dressings), By End User ,By Region - Global Market Forecast 2020-2030 CRISPR and Cas Genes Market - CRISPR and Cas Genes Market By Product (Vector-based Cas, DNA-free Cas), By Application (Genome Engineering, Disease Models, Functional Genomes, Knockdown/Activation), By End User, By Region - Global Mraket Forecast 2020-2030 Viral Antigens Market - Viral Antigens Market By Component (Influenza, Coronavirus, Zika Virus, Ebola Virus, Dengue Virus, Rotavirus Viral & Epstein-Barr Virus Antigens, Others), By Technique, By End-User, By Region - Global Mraket Forecast 2020-2030 Medical Education Market - Medical Education Market By Mode of Training (On-campus, Distance), By Types of Training (Cardiothoracic, Neurology, Orthopedic, Oral and Maxillofacial, Pediatric & Radiology Training), By Type of Organization, By Delivery Method, By Region - Global Insights 2030 Diabetic Neuropathy Market - Diabetic Neuropathy Market Forecast, Trend, Analysis & Competition Tracking By Disorder (Peripheral, Autonomic, Proximal, Focal), By Treatment (Drugs, Analgesic, Antidepressants, Anticonvulsant Drugs, Radiotherapy) - Global Market Insights 2020 to 2025 About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner. Contact: Mahendra Singh US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 Email: sales@factmr.com Tel: +1 (628) 251-158
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.